[go: up one dir, main page]

SE0202464D0 - Use of compounds - Google Patents

Use of compounds

Info

Publication number
SE0202464D0
SE0202464D0 SE0202464A SE0202464A SE0202464D0 SE 0202464 D0 SE0202464 D0 SE 0202464D0 SE 0202464 A SE0202464 A SE 0202464A SE 0202464 A SE0202464 A SE 0202464A SE 0202464 D0 SE0202464 D0 SE 0202464D0
Authority
SE
Sweden
Prior art keywords
diseases
driven
compounds
conditions
cell
Prior art date
Application number
SE0202464A
Other languages
English (en)
Inventor
Per-Olof Ericsson
Karin Kristensson
Pascalis Sideras
Peter Sjoe
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0202464A priority Critical patent/SE0202464D0/sv
Publication of SE0202464D0 publication Critical patent/SE0202464D0/sv
Priority to AU2003251271A priority patent/AU2003251271A1/en
Priority to PCT/SE2003/001274 priority patent/WO2004016270A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0202464A 2002-08-14 2002-08-14 Use of compounds SE0202464D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0202464A SE0202464D0 (sv) 2002-08-14 2002-08-14 Use of compounds
AU2003251271A AU2003251271A1 (en) 2002-08-14 2003-08-13 USE OF Itk INHIBITORS FOR THE TREATMENT OF MAST CELL-DRIVEN OR BASOPHIL-DRIVEN DISEASES
PCT/SE2003/001274 WO2004016270A1 (en) 2002-08-14 2003-08-13 USE OF Itk INHIBITORS FOR THE TREATMENT OF MAST CELL-DRIVEN OR BASOPHIL-DRIVEN DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202464A SE0202464D0 (sv) 2002-08-14 2002-08-14 Use of compounds

Publications (1)

Publication Number Publication Date
SE0202464D0 true SE0202464D0 (sv) 2002-08-14

Family

ID=20288752

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202464A SE0202464D0 (sv) 2002-08-14 2002-08-14 Use of compounds

Country Status (3)

Country Link
AU (1) AU2003251271A1 (sv)
SE (1) SE0202464D0 (sv)
WO (1) WO2004016270A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080146585A1 (en) * 2004-04-20 2008-06-19 Ab Science Use Of C-Kit Inhibitors For Treating Inflammatory Muscle Disorders Including Myositis And Muscular Dystrophy
WO2013153539A1 (en) 2012-04-13 2013-10-17 Glenmark Pharmaceuticals S.A. Tricyclic compounds as tec kinase inhibitors
CN103804381A (zh) * 2012-11-06 2014-05-21 韩冰 一类治疗缺血性脑损伤的化合物及其用途
CA2973773C (en) 2015-02-02 2023-10-17 Kancera Ab 2-phenyl-3h-imidazo[4,5-b]pyridine derivatives useful as inhibitors of mammalian tyrosine kinase ror1 activity
KR102466810B1 (ko) 2016-07-11 2022-11-11 칸세라 아베 포유류 티로신 키나제 ror1 활성의 저해제로서 유용한 2-페닐이미다조[4,5-b]피리딘-7-아민 유도체
US11660303B2 (en) 2016-07-11 2023-05-30 Kancera Ab 2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity
EP4263538A1 (en) * 2020-12-15 2023-10-25 Pfizer Inc. Pyrido[2,3-d]imidazole derivatives and their use as inhibitors of itk for the teatment of skin disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200001312T2 (tr) * 1997-11-10 2000-09-21 Bristol-Myers Squibb Company Benzotiyazol protein tirozin kinaz önleyicileri.
CA2386218A1 (en) * 1999-10-07 2001-04-12 Amgen Inc. Triazine kinase inhibitors
HRP20020547B1 (hr) * 1999-12-24 2011-06-30 Aventis Pharma Limited Azaindoli
DK1347971T3 (da) * 2000-12-21 2006-05-15 Bristol Myers Squibb Co Thiazolylinhibitorer af tyrosinkinaser fra Tec-familien

Also Published As

Publication number Publication date
AU2003251271A1 (en) 2004-03-03
WO2004016270A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
NO20052928L (no) Nye kjemiske forbindelser
SG170813A1 (en) New compounds
TN2009000128A1 (en) Dihydropyridine derivatives useful as protein kinase inhibitors
NO20073068L (no) Stereoisomere anrikete 3-aminokarbonylbisykloheptenpyrimidindiaminforindelser og deres anvendelse
BRPI0517015A (pt) compostos e composições como inibidores de atividade de receptor 1 de canabinóide
MX2009004047A (es) Compuestos organicos.
ATE441418T1 (de) Verwendung von treprostinil zur verbesserung der nierenfunktion
TW200607513A (en) Certain chemical entities, compositions, and methods
NO20064895L (no) 6,6-Bisykliske ring-substituerte heterobisykliske protein-kinase inhibitorer
ATE469151T1 (de) Pyrrolopyridinderivate als proteinkinaseinhibitoren
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
AU3741801A (en) Substituted beta-carbolines with ikb-kinase inhibiting activity
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
WO2006034113A3 (en) Quinolone analogs as cell proliferation inhibitors
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
SE0202464D0 (sv) Use of compounds
DE60329326D1 (de) Tace inhibitoren
MX2010005650A (es) Derivados de diazabicicloalcano substituidos con biarilo.
ATE380188T1 (de) Substituierte chinolone
TW200716132A (en) Novel chemical compounds
TW200726763A (en) Novel compound
MX2009012079A (es) Compuestos heterociclicos condensados como inhibidores de proteina cinasas.
NO20072048L (no) Anvendelse av IL-17F for behandling og/eller forebygging av neurologiske sykdommer.